NLS Pharmaceutics Ltd. (NCEL)
Market Open
12 Jun, 13:41
NASDAQ (CM) NASDAQ (CM) Primary $
3. 35
+0.08
+2.5688%
$
1.32M Market Cap
- P/E Ratio
- Div Yield
2,692 Volume
- Eps
$ 3.27
Previous Close Investors:
Want to track NCEL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NLS Pharmaceutics Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CAL CoreCap Advisors LLC CoreCap Advisors LLC | 3 | $5.7 | $9.81 | $4.11 | 72.11% |
